Abstract
The causative agent of cholera, Vibrio cholerae, is a public health concern. Multidrug-resistant V. cholerae variants may reduce chemotherapeutic efficacies of severe cholera. We previously reported that the multidrug efflux pump EmrD-3 from V. cholerae confers resistance to multiple structurally distinct antimicrobials. Medicinal plant compounds are potential candidates for EmrD-3 efflux pump modulation. The antibacterial activities of garlic Allium sativum, although poorly understood, predicts that a main bioactive component, allyl sulfide, modulates EmrD-3 efflux. Thus, we tested whether A. sativum extract acts in synergy with antimicrobials and that a main bioactive component allyl sulfide inhibits EmrD-3 efflux. We found that A. sativum extract and allyl sulfide inhibited ethidium bromide efflux in cells harboring EmrD-3 and that A. sativum lowered the MICs of multiple antibacterials. We conclude that A. sativum and allyl sulfide inhibit EmrD-3 and that A. sativum extract synergistically enhances antibacterial agents.
Similar content being viewed by others
References
Alsaid M, Daud H, Bejo SK, Abuseliana A (2010) Antimicrobial activities of some culinary spice extracts against Streptococcus agalactiae and its prophylactic uses to prevent streptococcal infection in red hybrid tilapia (Oreochromis sp.). World J Fish Marine Sci 2(6):532–538
Andersen JL, He GX, Kakarla P, KC R, Kumar S, Lakra WS, Mukherjee MM, Ranaweera I, Shrestha U, Tran T, Varela MF (2015) Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health 12(2):1487–1547. doi:10.3390/ijerph120201487
Avato P, Tursil E, Vitali C, Miccolis V, Candido V (2000) Allylsulfide constituents of garlic volatile oil as antimicrobial agents. Phytomedicine 7(3):239–243
Barrero MA, Pietralonga PA, Schwarz DG, Silva A Jr, Paula SO, Moreira MA (2014) Effect of the inhibitors phenylalanine arginyl β-naphthylamide (PAβN) and 1-(1-naphthylmethyl)-piperazine (NMP) on expression of genes in multidrug efflux systems of Escherichia coli isolates from bovine mastitis. Res Vet Sci 97(2):176–181. doi:10.1016/j.rvsc.2014.05.013
Bhardwaj AK, Mohanty P (2012) Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy. Recent Pat Anti infect Drug Discov 7(1):73–89
Blair JM, Richmond GE, Piddock LJ (2014) Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol 9(10):1165–1177. doi:10.2217/fmb.14.66
Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ (2015) Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13(1):42–51. doi:10.1038/nrmicro3380
Bolton S, Null G, Troetel WM (1982) The medical uses of garlic–fact and fiction. Am Pharm NS22 8:40–43
Chen J, Morita Y, Huda MN, Kuroda T, Mizushima T, Tsuchiya T (2002) VmrA, a member of a novel class of Na+ -coupled multidrug efflux pumps from Vibrio parahaemolyticus. J Bacteriol 184(2):572–576
Chen J, Kuroda T, Huda MN, Mizushima T, Tsuchiya T (2003) An RND-type multidrug efflux pump SdeXY from Serratia marcescens. J Antimicrob Chemother 52(2):176–179. doi:10.1093/jac/dkg308
Chung YJ, Saier MH Jr (2001) SMR-type multidrug resistance pumps. Curr Opin Drug Discov Dev 4(2):237–245
Chung JG, Chen GW, Wu LT, Chang HL, Lin JG, Yeh CC, Wang TF (1998) Effects of garlic compounds diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Am J Chin Med 26(3–4):353–364. doi:10.1142/S0192415X98000397
Dini C, Fabbri A, Geraci A (2011) The potential role of garlic (Allium sativum) against the multi-drug resistant tuberculosis pandemic: a review. Ann Ist Super Sanita 47(4):465–473. doi:10.4415/ANN_11_04_18
Dymek A, Armada A, Handzlik J, Viveiros M, Spengler G, Molnar J, Kiec-Kononowicz K, Amaral L (2012) The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus. Vivo 26(2):223–229
Faruque SM, Albert MJ, Mekalanos JJ (1998) Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev 62(4):1301–1314
Floyd JL, Smith KP, Kumar SH, Floyd JT, Varela MF (2010) LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agents Chemother 54(12):5406–5412. doi:10.1128/AAC.00580-10
Floyd JL, Kumar S, Mukherjee MM, He G, Varela MF (2013) A review of the molecular mechanisms of drug efflux in pathogenic bacteria: a structure-function perspective. Recent Res. Devel. Membrane Biol, vol 3. Research Signpost, Inc, Trivandrum, pp 15–66
Ghosh A, Ramamurthy T (2011) Antimicrobials and cholera: are we stranded? Indian J Med Res 133:225–231
Goncagul G, Ayaz E (2010) Antimicrobial effect of garlic (Allium sativum). Recent Pat Antiinfect Drug Discov 5(1):91–93
Harris JC, Cottrell SL, Plummer S, Lloyd D (2001) Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol 57(3):282–286
He GX, Kuroda T, Mima T, Morita Y, Mizushima T, Tsuchiya T (2004) An H+ -coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeruginosa. J Bacteriol 186(1):262–265
He GX, Thorpe C, Walsh D, Crow R, Chen H, Kumar S, Varela MF (2011a) EmmdR, a new member of the MATE family of multidrug transporters, extrudes quinolones from Enterobacter cloacae. Arch Microbiol 193(10):759–765. doi:10.1007/s00203-011-0738-1
He GX, Zhang C, Crow RR, Thorpe C, Chen H, Kumar S, Tsuchiya T, Varela MF (2011b) SugE, a new member of the SMR family of transporters, contributes to antimicrobial resistance in Enterobacter cloacae. Antimicrob Agents Chemother 55(8):3954–3957. doi:10.1128/AAC.00094-11
He GX, Landry M, Chen H, Thorpe C, Walsh D, Varela MF, Pan H (2014) Detection of benzalkonium chloride resistance in community environmental isolates of staphylococci. J Med Microbiol 63(Pt 5):735–741. doi:10.1099/jmm.0.073072-0
Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, Gill SR, Nelson KE, Read TD, Tettelin H, Richardson D, Ermolaeva MD, Vamathevan J, Bass S, Qin H, Dragoi I, Sellers P, McDonald L, Utterback T, Fleishmann RD, Nierman WC, White O, Salzberg SL, Smith HO, Colwell RR, Mekalanos JJ, Venter JC, Fraser CM (2000) DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nature 406(6795):477–483. doi:10.1038/35020000
Horiyama T, Yamaguchi A, Nishino K (2010) TolC dependency of multidrug efflux systems in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 65(7):1372–1376. doi:10.1093/jac/dkq160
Hsieh MH, Yu CM, Yu VL, Chow JW (1993) Synergy assessed by checkerboard. A critical analysis. Diagn Microbiol Infect Dis 16(4):343–349
Iwalokun BA, Ogunledun A, Ogbolu DO, Bamiro SB, Jimi-Omojola J (2004) In vitro antimicrobial properties of aqueous garlic extract against multidrug-resistant bacteria and Candida species from Nigeria. J Med Food 7(3):327–333. doi:10.1089/jmf.2004.7.327
Kahne D, Leimkuhler C, Lu W, Walsh C (2005) Glycopeptide and lipoglycopeptide antibiotics. Chem Rev 105(2):425–448. doi:10.1021/cr030103a
Kitaoka M, Miyata ST, Unterweger D, Pukatzki S (2011) Antibiotic resistance mechanisms of Vibrio cholerae. J Med Microbiol 60(Pt 4):397–407. doi:10.1099/jmm.0.023051-0
Krieg PA, Melton DA (1987) In vitro RNA synthesis with SP6 RNA polymerase. Methods Enzymol 155:397–415
Kumar A, Schweizer HP (2005) Bacterial resistance to antibiotics: active efflux and reduced uptake. Adv Drug Deliv Rev 57(10):1486–1513. doi:10.1016/j.addr.2005.04.004
Kumar S, Varela MF (2012) Biochemistry of bacterial multidrug efflux pumps. Int J Mol Sci 13(4):4484–4495. doi:10.3390/ijms13044484
Kumar S, Varela MF (2013) Molecular mechanisms of bacterial resistance to antimicrobial agents. In: Méndez-Vilas A (ed) Microbial pathogens and strategies for combating them: science, technology and education. Formatex Research Center, Inc., Badajoz, Spain, pp 522–534
Kumar S, Mukherjee MM, Varela MF (2013a) Modulation of bacterial multidrug resistance efflux pumps of the major facilitator superfamily. Int J Bacteriol. doi:10.1155/2013/204141
Kumar S, Floyd JT, He G, Varela MF (2013b) Bacterial antimicrobial efflux pumps of the MFS and MATE transporter families: a review. In: Shankar P (ed) Recent research developments in antimicrobial agents and chemotherapy, vol 7. Research Signpost Inc, Trivandrum, pp 1–21
Kumar S, Lindquist IE, Sundararajan A, Rajanna C, Floyd JT, Smith KP, Andersen JL, He G, Ayers RM, Johnson JA, Werdann JJ, Sandoval AA, Mojica NM, Schilkey FD, Mudge J, Varela MF (2013c) Genome Sequence of Non-O1 Vibrio cholerae PS15. Genome Announc. doi:10.1128/genomeA.00227-12
Kumar S, He G, Kakarla P, Shrestha U, Ranjana KC, Ranaweera I, Mark Willmon T, Barr SR, Hernandez AJ, Varela MF (2016) Bacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for Modulation. Infect Disord Drug Targets 16:28–43. doi:10.2174/1871526516666160407113848
Kuroda T, Tsuchiya T (2009) Multidrug efflux transporters in the MATE family. Biochim Biophys Acta 1794(5):763–768. doi:10.1016/j.bbapap.2008.11.012
Lage H (2003) ABC-transporters: implications on drug resistance from microorganisms to human cancers. Int J Antimicrob Agents 22(3):188–199
Leibovici-Weissman Y, Neuberger A, Bitterman R, Sinclair D, Salam MA, Paul M (2014) Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev 6:CD008625. doi:10.1002/14651858.CD008625.pub2
Levy SB (1989) Evolution and spread of tetracycline resistance determinants. J Antimicrob Chemother 24(1):1–3
Lewis K (2001) In search of natural substrates and inhibitors of MDR pumps. J Mol Microbiol Biotechnol 3(2):247–254
Lomovskaya O, Watkins W (2001a) Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J Mol Microbiol Biotechnol 3(2):225–236
Lomovskaya O, Watkins WJ (2001b) Efflux pumps: their role in antibacterial drug discovery. Curr Med Chem 8(14):1699–1711
Mekalanos JJ (1983) Duplication and amplification of toxin genes in Vibrio cholerae. Cell 35(1):253–263
Mikaili P, Maadirad S, Moloudizargari M, Aghajanshakeri S, Sarahroodi S (2013) Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds. Iran J Basic Med Sci 16(10):1031–1048
Mukherjee M, Kakarla P, Kumar S, Gonzalez E, Floyd JT, Inupakutika M, Devireddy AR, Tirrell SR, Bruns M, He G, Lindquist IE, Sundararajan A, Schilkey FD, Mudge J, Varela MF (2014) Comparative genome analysis of non-toxigenic non-O1 versus toxigenic O1 Vibrio cholerae. Genom Discov 2(1):1–15. doi:10.7243/2052-7993-2-1
Mukherjee MM, Kumar S, Shrestha U, Ranaweera I, KC R, Kakarla P, Willmon TM, Hernandez AJ, He G, Lau C, Barr SR, Varela MF (2016) Comparative genomics and discovery of novel cellular targets for the development of new therapeutics towards Vibrio cholerae, the causative agent of cholera disease. Anti Infect Agents 14(2):88–99. doi:10.2174/2211352514666160816151125
Nikaido H, Takatsuka Y (2009) Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta 1794(5):769–781. doi:10.1016/j.bbapap.2008.10.004
Odds FC (2003) Synergy, antagonism, and what the chequer board puts between them. J Antimicrob Chemother 52(1):1. doi:10.1093/jac/dkg301
Opperman TJ, Nguyen ST (2015) Recent advances toward a molecular mechanism of efflux pump inhibition. Front Microbiol 6:421. doi:10.3389/fmicb.2015.00421
Otsuka M, Yasuda M, Morita Y, Otsuka C, Tsuchiya T, Omote H, Moriyama Y (2005) Identification of essential amino acid residues of the NorM Na+/ multidrug antiporter in Vibrio parahaemolyticus. J Bacteriol 187(5):1552–1558. doi:10.1128/JB.187.5.1552-1558.2005
Pages JM, Amaral L (2009) Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 1794(5):826–833. doi:10.1016/j.bbapap.2008.12.011
Paulsen IT, Brown MH, Skurray RA (1996) Proton-dependent multidrug efflux systems. Microbiol Rev 60(4):575–608
Piddock LJ (1999) Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58(Suppl 2):11–18
Ping Y, Ogawa W, Kuroda T, Tsuchiya T (2007) Gene cloning and characterization of KdeA, a multidrug efflux pump from Klebsiella pneumoniae. Biol Pharm Bull 30(10):1962–1964
Platt D (1988) Memoire sur la fermentation appelee lactique (Louis Pasteur). Del Med J 60(1):23–24
Putman M, Koole LA, van Veen HW, Konings WN (1999) The secondary multidrug transporter LmrP contains multiple drug interaction sites. Biochemistry 38(42):13900–13905
Saidijam M, Benedetti G, Ren Q, Xu Z, Hoyle CJ, Palmer SL, Ward A, Bettaney KE, Szakonyi G, Meuller J, Morrison S, Pos MK, Butaye P, Walravens K, Langton K, Herbert RB, Skurray RA, Paulsen IT, O’Reilly J, Rutherford NG, Brown MH, Bill RM, Henderson PJ (2006) Microbial drug efflux proteins of the major facilitator superfamily. Curr Drug Targets 7(7):793–811
Schindler BD, Jacinto P, Kaatz GW (2013) Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics. Future Microbiol 8(4):491–507. doi:10.2217/fmb.13.16
Smith KP, Kumar S, Varela MF (2009) Identification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395. Arch Microbiol 191(12):903–911. doi:10.1007/s00203-009-0521-8
Tattelman E (2005) Health effects of garlic. Am Fam Phys 72(1):103–106
Varela MF, Kumar S, He G (2013) Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholerae. Indian J Med Res 138(3):285–287
Vijaya K, Ananthan S (1997) Microbiological screening of Indian medicinal plants with special reference to enteropathogens. J Altern Complement Med 3(1):13–20
Zhang L, Ma S (2010) Efflux pump inhibitors: a strategy to combat P-glycoprotein and the NorA multidrug resistance pump. ChemMedChem 5(6):811–822. doi:10.1002/cmdc.201000006
Acknowledgements
We thank Dr. Gary Calton for helpful comments. This work was supported by an Internal Research Grant (ENMU) and by the US Department of Education, HSI STEM, P031C110114.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Yusuf Akhter.
Rights and permissions
About this article
Cite this article
Bruns, M.M., Kakarla, P., Floyd, J.T. et al. Modulation of the multidrug efflux pump EmrD-3 from Vibrio cholerae by Allium sativum extract and the bioactive agent allyl sulfide plus synergistic enhancement of antimicrobial susceptibility by A. sativum extract. Arch Microbiol 199, 1103–1112 (2017). https://doi.org/10.1007/s00203-017-1378-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-017-1378-x